Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Liabilities (2023 - 2024)

Historic Other Non-Current Liabilities for Contineum Therapeutics (CTNM) over the last 2 years, with Q1 2024 value amounting to $228000.0.

  • Contineum Therapeutics' Other Non-Current Liabilities changed N/A to $228000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $228000.0, marking a year-over-year change of. This contributed to the annual value of $110000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Other Non-Current Liabilities of $228000.0 as of Q1 2024.
  • Over the past 5 years, Contineum Therapeutics' Other Non-Current Liabilities peaked at $228000.0 during Q1 2024, and registered a low of $110000.0 during Q4 2023.